 |
|
|
| |
HBV RNAi INHIBITOR RG6346 IN PHASE 1b-2a TRIAL WAS SAFE, WELL-TOLERATED, AND RESULTED IN SUBSTANTIAL AND DURABLE
REDUCTIONS IN SERUM HBsAg LEVELS
|
| |
| |
AASLD 2020 Nov 11-16
Reported by Jules Levin
Mon-Fung Yuen'. Tien Huey Lim', Won Kim", Pisit Tongkijvonich', Jung-Hwon Yoon', William Sievert\ Wotton Sukeepoisornjoroen', Alexander Thompson", Christion Schwabe", Bob D. Brown", Hord eon E. Achnecl<", and Edward J. Gone'
'Queen Mary Hospital, the University of Hong Kong. Hong Kong:· Middlemore Hospital, Aucl< lond. NZ: 'Boramoe Medical Center, Seoul National University Hospital, Seoul, Korea: ·'King Chulalongkorn Memorial Hospital. Bangkol<: 'Seoul National University Hospital, Seoul. South Korea: ''Monash Health and Monash University. Melbourne. Australia: 'Srinagarind Hospital. Khan Koen University, Thailand: 'St Viment's Hospital Melbourne. Australia: ·New Zealand Liver Transplant Unit Auckland City Hospital and University of Auckland. Auckland, New Zealand: ·, Oicerno Pharmoceutirnls Inc .. Lexington. MA. USA
|
| |
|
|
|
|
|
